Search Results - "Rossi, Emma C."

Refine Results
  1. 1
  2. 2
  3. 3

    Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival by Barber, Emma L, Dusetzina, Stacie B, Stitzenberg, Karyn B, Rossi, Emma C, Gehrig, Paola A, Boggess, John F, Garrett, Joanne M

    Published in Gynecologic oncology (01-06-2017)
    “…Highlights • Neoadjuvant chemotherapy use varied widely, from 5 to 55%, among high volume hospitals. • Hospital level patterns of neoadjuvant chemotherapy use…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Implementation and evaluation of a novel subspecialty society fellows robotic surgical course: the SGO minimally invasive academy surgical curriculum by Boitano, Teresa K L, Smith, Haller J, Cohen, Joshua G, Rossi, Emma C, Kim, Kenneth H

    Published in Journal of gynecologic oncology (01-03-2021)
    “…To evaluate the utility of a society-based robotic surgery training program for fellows in gynecologic oncology. All participants underwent a 2-day robotic…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Current state of sentinel lymph nodes for women with endometrial cancer by Rossi, Emma C

    “…Sentinel lymph node (SLN) biopsy has been investigated as an alternative to conventional pelvic and para-aorticlymphadenectomy for the surgical staging of…”
    Get more information
    Journal Article
  8. 8

    Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread by Sullivan, Stephanie A., Hawkins, Gabriel, Zhao, Xiobai, Jo, Heejoon, Hayes, Neil, Deng, Xiaoyan, Bandyopadhyay, Dipankar, Bae-Jump, Victoria L., Rossi, Emma C.

    Published in Gynecologic oncology reports (01-05-2021)
    “…•TP53 mutations are common in serous endometrial tumors.•Endometrial tumors with micro and macrometastasis are more likely than tumors with ITC only to have…”
    Get full text
    Journal Article
  9. 9

    Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies by Rossi, Emma C., Tanner, Edward

    Published in Journal of minimally invasive gynecology (01-03-2021)
    “…Sentinel lymph node (SLN) biopsy represents an evolution in the advancement of minimally invasive surgical techniques for gynecologic cancers. Prospective and…”
    Get full text
    Journal Article
  10. 10

    Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study by Rossi, Emma C, Ivanova, Anastasia, Boggess, John F

    Published in Gynecologic oncology (01-01-2012)
    “…Abstract Objective Traditional techniques of sentinel lymph node (SLN) mapping for endometrial and cervical cancer present challenges which may be overcome…”
    Get full text
    Journal Article
  11. 11

    Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations by Holloway, Robert W, Abu-Rustum, Nadeem R, Backes, Floor J, Boggess, John F, Gotlieb, Walter H, Jeffrey Lowery, W, Rossi, Emma C, Tanner, Edward J, Wolsky, Rebecca J

    Published in Gynecologic oncology (01-08-2017)
    “…Abstract The emphasis in contemporary medical oncology has been “precision” or “personalized” medicine, terms that imply a strategy to improve efficacy through…”
    Get full text
    Journal Article
  12. 12

    Extent of lymphadenectomy and postoperative major complications among women with endometrial cancer treated with minimally invasive surgery by Polan, Rosa M., Rossi, Emma C., Barber, Emma L.

    “…In patients with endometrial cancer, sentinel lymphadenectomy is used to accurately prognosticate extent of disease, and has been proposed as a method to…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Sentinel-lymph-node mapping in endometrial cancer – Authors' reply by Rossi, Emma C

    Published in The lancet oncology (01-05-2017)
    “…Ultimately, to determine whether the limitations of sentinel lymph node biopsy to characterise the extent of nodal metastases negatively affects outcomes for…”
    Get full text
    Journal Article
  15. 15

    Cytokine use and survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group Study by Stehman, Frederick B, Brady, Mark F, Thigpen, J. Tate, Rossi, Emma C, Burger, Robert A

    Published in Gynecologic oncology (01-12-2012)
    “…Abstract Background Granulocyte colony stimulating factor (G-CSF) and erythropoietin stimulating agents (ESA) may be used to support patients during…”
    Get full text
    Journal Article
  16. 16

    Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection by Rossi, Emma C, Jackson, Amanda, Ivanova, Anastasia, Boggess, John F

    “…Sentinel lymph node (SLN) mapping with indocyanine green (ICG) detected by robotic near infrared (NIR) imaging is a feasible technique. The optimal site of…”
    Get more information
    Journal Article
  17. 17

    Delayed publication of clinical trials in gynecologic oncology by Salinaro, Julia R., Rossi, Emma C., Penvose, Katherine N., Zhang, Yingao, Darling, Alice J.

    Published in Gynecologic oncology (01-04-2024)
    “…Delays in clinical trial publication can hinder timely implementation of evidence-based practices. We sought to determine publication rates and time to…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Controversies in the Surgical Management of Gynecologic Cancer: Balancing the Decision to Operate or Hesitate by Somasegar, Sahana, Anastasio, Mary Katherine, Karam, Amer, Rossi, Emma C, Obermair, Andreas

    “…Cancer outcomes are largely measured in terms of disease-free survival or overall survival, which is highly dependent on timely diagnosis and access to…”
    Get more information
    Journal Article